Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Cattaneo C, Cairoli R, Rossi G. Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors. Cancer 2021;127:1939. [PMID: 33721356 PMCID: PMC8251462 DOI: 10.1002/cncr.33431] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 12/22/2020] [Indexed: 11/06/2022]

For:	Cattaneo C, Cairoli R, Rossi G. Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors. Cancer 2021;127:1939. [PMID: 33721356 PMCID: PMC8251462 DOI: 10.1002/cncr.33431] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 12/22/2020] [Indexed: 11/06/2022]

Number

Cited by Other Article(s)

Cattaneo C, Cairoli R, Rossi G. Reply to COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors. Cancer 2021;127:1939. [PMID: 33721356 PMCID: PMC8251462 DOI: 10.1002/cncr.33431] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2020] [Accepted: 12/22/2020] [Indexed: 11/06/2022]